Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $103,599,594.95
- Sept. 16, 2024
- Alec Machiels
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 20, 2023 | Director | 1,250 | $88.41 | Sell | $110,512.50 | |
June 8, 2023 | Insider | 12,000 | $91.35 | Sell | $1,096,200.00 | |
June 5, 2023 | CFO | 69,779 | $88.80 | Sell | $6,196,375.20 | |
June 1, 2023 | Insider | 5,000 | $86.00 | Sell | $430,000.00 | |
May 17, 2023 | Director | 1,250 | $88.66 | Sell | $110,825.00 | |
May 16, 2023 | CEO | 30,000 | $85.66 | Sell | $2,569,800.00 | |
May 8, 2023 | Insider | 12,000 | $92.39 | Sell | $1,108,680.00 | |
May 3, 2023 | Insider | 5,000 | $82.71 | Sell | $413,550.00 | |
April 18, 2023 | CEO | 30,000 | $82.02 | Sell | $2,460,600.00 | |
April 17, 2023 | Director | 1,250 | $81.05 | Sell | $101,312.50 | |
April 10, 2023 | Insider | 12,000 | $78.21 | Sell | $938,520.00 | |
April 3, 2023 | Director | 500 | $74.05 | Sell | $37,025.00 | |
April 3, 2023 | Insider | 5,000 | $75.00 | Sell | $375,000.00 | |
March 21, 2023 | CEO | 30,000 | $62.74 | Sell | $1,882,200.00 | |
March 17, 2023 | Director | 1,250 | $64.03 | Sell | $80,037.50 | |
March 8, 2023 | Insider | 12,000 | $63.79 | Sell | $765,480.00 | |
Feb. 23, 2023 | Insider | 1,646 | $68.76 | Sell | $113,178.96 | |
Feb. 8, 2023 | Insider | 12,000 | $54.45 | Sell | $653,400.00 | |
Feb. 3, 2023 | Insider | 5,000 | $55.85 | Sell | $279,250.00 | |
Jan. 30, 2023 | Insider | 883 | $52.76 | Sell | $46,587.08 | |
Jan. 23, 2023 | Insider | 2,955 | $51.58 | Sell | $152,418.90 | |
Jan. 17, 2023 | Director | 1,250 | $52.42 | Sell | $65,525.00 | |
Jan. 9, 2023 | Insider | 12,000 | $46.08 | Sell | $552,960.00 | |
Jan. 5, 2023 | Insider | 2,500 | $48.79 | Sell | $121,975.00 | |
Jan. 3, 2023 | Director | 500 | $50.70 | Sell | $25,350.00 | |
Jan. 3, 2023 | Insider | 5,000 | $50.70 | Sell | $253,500.00 | |
Dec. 19, 2022 | CEO | 28,200 | $52.06 | Sell | $1,468,092.00 | |
Dec. 15, 2022 | Director | 1,250 | $52.35 | Sell | $65,437.50 | |
Dec. 8, 2022 | Insider | 12,000 | $47.50 | Sell | $570,000.00 | |
Dec. 5, 2022 | Insider | 5,000 | $50.38 | Sell | $251,900.00 | |
Dec. 1, 2022 | Director | 500 | $49.93 | Sell | $24,965.00 | |
Dec. 1, 2022 | Insider | 2,500 | $49.93 | Sell | $124,825.00 | |
Nov. 8, 2022 | Insider | 12,000 | $46.47 | Sell | $557,640.00 | |
Nov. 3, 2022 | Insider | 5,000 | $58.54 | Sell | $292,700.00 | |
Oct. 14, 2022 | Director | 1,250 | $59.31 | Sell | $74,137.50 | |
Oct. 10, 2022 | Insider | 12,000 | $57.50 | Sell | $690,000.00 | |
Oct. 3, 2022 | Insider | 2,500 | $66.69 | Sell | $166,725.00 | |
Sept. 15, 2022 | Director | 1,250 | $66.00 | Sell | $82,500.00 | |
Sept. 8, 2022 | Insider | 12,000 | $63.98 | Sell | $767,760.00 | |
Aug. 17, 2022 | SVP | 5,000 | $69.50 | Sell | $347,500.00 | |
Aug. 15, 2022 | Insider | 12,500 | $69.00 | Sell | $862,500.00 | |
Aug. 15, 2022 | Director | 1,250 | $67.21 | Sell | $84,012.50 | |
Aug. 11, 2022 | SVP | 5,000 | $67.00 | Sell | $335,000.00 | |
Aug. 11, 2022 | Director | 30,000 | $65.63 | Sell | $1,968,900.00 | |
Aug. 11, 2022 | Insider | 12,500 | $67.00 | Sell | $837,500.00 | |
Aug. 3, 2022 | Insider | 5,000 | $56.43 | Sell | $282,150.00 | |
Aug. 1, 2022 | Insider | 2,500 | $55.99 | Sell | $139,975.00 | |
July 27, 2022 | SVP | 5,000 | $57.00 | Sell | $285,000.00 | |
July 19, 2022 | SVP | 5,000 | $56.42 | Sell | $282,100.00 | |
July 15, 2022 | Director | 1,250 | $46.33 | Sell | $57,912.50 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Federico Grossi, Cedric Francois, Pascal Deschatelets, A. Sinclair Dunlop, Mark Jeffrey Delong, David O Watson, Adam J Townsend, Lukas Scheibler, Timothy Eugene Sullivan, Nicole D Perry, James George Chopas, Jeffrey Eisele, Morningside Venture Investment, Karen Lewis, Nur Nicholson, Global Strategic Fund I Venbio, Victoria L. Brown, Deschatelets Pascal, Caroline Baumal, Victoria L Brown, and Machiels Alec
The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $50,716,137.07.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on Sept. 16, 2024.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.